IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
$14.22
-0.07% today · +29.27% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- IOVA −0.07% on the last session vs SPY +0.74%: −0.8 pts of stock-specific move.
- Aftermath, big gain (Sep 29): After its 63 big gains in the past 5 years, IOVA typically gained 1.0% over the next day (median) and was higher 56% of the time; half the outcomes fell between -2.9% and +3.5%. An ordinary day: -0.3%. Among S&P 500 stocks after big gains, that ranks #168 of 500.
- 1 Reddit mentions in the past 24 hours, 82% positive over the week.
- 2 analyst actions in the past 10 days (2 positive, 0 negative); latest: Wells Fargo maintained Overweight, raised target $14.00 → $18.00.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 5
Before the open · in 32 days
EPS estimate
−$0.09
−$0.10 to −$0.07 · 8 analysts
Revenue estimate
$113.2M
$107.9M to $118.4M
Track record
4/8 beats
last 8 reports · moved ±24.4% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 BMO | 2Q2026 | −$0.13 | −$0.11 | +$0.02 (+18.4%) beat | $99.3M | +43.1% +43.2 vs SPY | +37.1% | +55.3% |
| May 7, 2026 BMO | 1Q2026 | −$0.15 | −$0.19 | −$0.04 (−23.8%) miss | $71.4M | -13.2% -12.9 vs SPY | -14.2% | -10.5% |
| Feb 24, 2026 BMO | 4Q2025 | −$0.18 | −$0.18 | −$0.00 (−2.1%) in line | $86.8M | +30.8% +30.1 vs SPY | +14.2% | +31.1% |
| Nov 6, 2025 BMO | 3Q2025 | −$0.26 | −$0.25 | +$0.01 (+2.8%) beat | $67.5M | +27.6% +28.7 vs SPY | +24.9% | +40.3% |
| Aug 7, 2025 AMC | −$0.28 | −$0.33 | −$0.05 (−17.9%) miss | — | -20.1% -20.9 vs SPY | -27.6% | -7.2% | |
| May 8, 2025 AMC | −$0.24 | −$0.36 | −$0.12 (−50.0%) miss | — | -44.8% -44.7 vs SPY | -38.8% | -44.5% | |
| Feb 26, 2025 AMC | −$0.27 | −$0.26 | +$0.01 (+3.7%) beat | — | -1.7% -0.1 vs SPY | +0.6% | -24.3% | |
| Nov 7, 2024 AMC | −$0.30 | −$0.28 | +$0.02 (+6.7%) beat | — | -13.8% -14.2 vs SPY | -13.1% | -30.1% | |
| Aug 8, 2024 AMC | −$0.35 | −$0.34 | +$0.01 (+2.9%) beat | — | +24.9% +24.5 vs SPY | +18.3% | +34.4% | |
| May 8, 2024 AMC | −$0.41 | −$0.42 | −$0.01 (−2.4%) miss | — | +0.5% -0.1 vs SPY | -0.1% | -20.2% | |
| Feb 28, 2024 AMC | −$0.43 | −$0.45 | −$0.02 (−4.7%) miss | — | -8.7% -9.1 vs SPY | -3.4% | -1.6% | |
| Nov 7, 2023 AMC | −$0.46 | −$0.46 | $0.00 (0.0%) in line | — | -3.5% -3.5 vs SPY | +3.9% | +9.0% | |
| Aug 8, 2023 AMC | −$0.79 | −$0.47 | +$0.32 (+40.5%) beat | — | +6.4% +7.1 vs SPY | -0.7% | +5.2% | |
| May 9, 2023 AMC | −$0.73 | −$0.50 | +$0.23 (+31.5%) beat | — | +3.8% +3.3 vs SPY | +3.5% | +1.8% | |
| Feb 28, 2023 AMC | −$0.64 | −$0.64 | $0.00 (0.0%) in line | — | +0.1% +0.5 vs SPY | +0.4% | -1.2% | |
| Nov 3, 2022 AMC | −$0.64 | −$0.63 | +$0.01 (+1.6%) beat | — | +4.3% +2.9 vs SPY | +5.7% | +1.6% | |
| Aug 4, 2022 AMC | −$0.61 | −$0.63 | −$0.02 (−3.3%) miss | — | -2.9% -2.7 vs SPY | -9.3% | -5.6% | |
| May 5, 2022 AMC | −$0.63 | −$0.58 | +$0.05 (+7.9%) beat | — | -2.5% -1.9 vs SPY | +0.2% | -15.4% | |
| Feb 24, 2022 AMC | −$0.56 | −$0.63 | −$0.07 (−12.5%) miss | — | +4.7% +2.5 vs SPY | -4.6% | -5.7% | |
| Nov 4, 2021 AMC | −$0.53 | −$0.55 | −$0.02 (−3.8%) miss | — | +2.0% +1.6 vs SPY | -2.1% | -4.1% | |
| Aug 5, 2021 AMC | −$0.51 | −$0.53 | −$0.02 (−3.9%) miss | — | — | — | — | |
| May 6, 2021 AMC | −$0.49 | −$0.51 | −$0.02 (−4.1%) miss | — | — | — | — | |
| Feb 25, 2021 AMC | −$0.44 | −$0.47 | −$0.03 (−6.8%) miss | — | — | — | — | |
| Nov 5, 2020 AMC | −$0.46 | −$0.40 | +$0.06 (+13.0%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | −$0.09 (8) | −$0.10 – −$0.07 | +65% | -30.6% | ▲1 ▼1 | $113.2M | +68% |
| Next quarter · Dec 31, 2026 | −$0.08 (8) | −$0.12 – −$0.04 | +53% | -29.3% | ▲1 ▼1 | $124.3M | +43% |
| Current year · Dec 31, 2026 | −$0.46 (8) | −$0.50 – −$0.41 | +58% | -19.0% | ▲6 ▼0 | $408.2M | +55% |
| Next year · Dec 31, 2027 | −$0.24 (8) | −$0.42 – −$0.10 | +48% | -25.7% | ▲1 ▼1 | $575.2M | +41% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.